Cell‐Based Drug Delivery Systems Participate in the Cancer Immunity Cycle for Improved Cancer Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cell‐Based Drug Delivery Systems Participate in the Cancer Immunity Cycle for Improved Cancer Immunotherapy

Published:2022-11-27 Issue:4 Volume:19 Page:2205166
ISSN:1613-6810
Container-title:Small
language:en
Short-container-title:Small

Author:

Fan Xiaoyuan¹,Wang Kaiyuan¹,Lu Qi¹,Lu Yutong¹,Sun Jin¹^ORCID

Affiliation:

1. Department of Pharmaceutics Wuya College of Innovation Shenyang Pharmaceutical University 103 Wenhua Road Shenyang Liaoning 110016 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Biomaterials,Biotechnology,General Materials Science,General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/smll.202205166

Reference201 articles.

1. Role of the Microbiota in Immunity and Inflammation

2. Advances in Engineering Cells for Cancer Immunotherapy

3. Oncology Meets Immunology: The Cancer-Immunity Cycle

4. The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors

5. Next generation of immune checkpoint inhibitors and beyond

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reactive oxygen species responsive chitooligosaccharides based nanoplatform for sonodynamic therapy in mammary cancer;Carbohydrate Polymers;2024-10

2. Neutrophil membrane-based biomimetic metal-polyphenol self-assembled nanozyme for the targeting treatment of early brain injury following subarachnoid hemorrhage;Chemical Engineering Journal;2024-09

3. Nano/genetically engineered cells for immunotherapy;BMEMat;2024-07-17

4. Exosomes as drug delivery systems in glioma immunotherapy;Journal of Nanobiotechnology;2024-06-18

5. Multi-effect coupling enhanced self-powered heterojunction ultraviolet photodetector with ultra-low detection limit;Materials Today;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3